Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Accenture
Federal Trade Commission
UBS
Covington
Baxter
Deloitte
Moodys
Express Scripts
McKinsey

Generated: August 17, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title: Methods of use for inhibiting bone loss and lowering serum cholesterol
Abstract:A method of inhibiting bone loss or resorption, or lowering serum cholesterol, comprising administering to a human in need thereof a compound having the formula ##STR1## or a pharmaceutically acceptable salt or solvate thereof, in a low dosage amount. Also encompased by the invention is a a pharmaceutical formulation in unit dosage form comprising, per unit dosage, a low dosage amount.
Inventor(s): Draper; Michael W. (Carmel, IN)
Assignee: Eli Lilly and Company (Indianapolis, IN)
Application Number:08/205,012
Patent Claims: 1. A method of inhibiting bone loss or bone resorption comprising administering to a human in need thereof a compound of formula I ##STR3## or a pharmaceutically acceptable salt or solvate thereof, in an amount of about 50 to 150 mg/day.

2. A method of claim 1 wherein the human has been diagnosed as suffering from osteoporosis.

3. A method of claim 1 wherein the human is a post-menopausal female.

4. A method of claim 1 wherein the human is a male.

5. A method of claim 1 wherein the compound is administered prophylactically.

6. A method of claim 1 wherein the compound of formula I is administered in an amount of about 60 to about 150 mg/day.

7. A method of claim 1 wherein the compound of formula I is administered in an amount of 60 mg/day.

8. A method of claim 1 wherein the compound of formula I is administered in an amount of 75 mg/day.

9. A method of claim 1 wherein the compound of formula I is administered in an amount of 100 mg/day.

10. A method of claim 1 wherein the compound of formula I is administered in an amount of 125 mg/day.

11. A method of claim 1 wherein the compound of formula I is administered in an amount of 150 mg/day.

12. A method of claim 1 wherein the compound is the hydrochloride salt.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Queensland Health
McKinsey
Boehringer Ingelheim
Julphar
Moodys
Healthtrust
Cerilliant
Federal Trade Commission
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot